Local Dose Finding Study(China. Maruho shall, in accordance with the Development Plan, confirm whether the Regulatory Authority in China will require a Phase IIb Clinical Trial with a Chinese population as a local dose finding study for any Product in the Field in China (the “Local Dose Finding Study (China)”).
Appears in 2 contracts
Sources: Sublicense Agreement (Evommune, Inc.), Sublicense Agreement (Evommune, Inc.)